Lv32
210 积分 2022-03-16 加入
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review
22小时前
已完结
Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter study
1个月前
已完结
Management of Bulky Inguinal and Pelvic Lymph Nodes
1个月前
已关闭
Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review
11个月前
已完结
Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer
1年前
已完结
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes
1年前
已完结
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial
1年前
已完结
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
1年前
已完结
Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma
1年前
已完结
Haemorrhagic cystitis: a review of management strategies and emerging treatments
1年前
已完结
皖公网安备34019202002308
